Key result
Machine learning models using 5 miRNAs discriminate HCM from controls with ~0.95 AUC.
Why the study?
Hypertrophic cardiomyopathy is an inherited cardiac disease with clinical diversity and sudden death risk that requires microRNA biomarker signatures for early detection, risk assessment, and personalised treatment.
Can integrated bioinformatics and machine learning models (SVM and Random Forest) utilizing differentially expressed miRNAs accurately distinguish hypertrophic cardiomyopathy tissue from healthy control tissue?
Can integrated bioinformatics and machine learning models (SVM and Random Forest) utilizing differentially expressed miRNAs accurately distinguish hypertrophic cardiomyopathy tissue from healthy control tissue?
Machine learning models trained on myocardial miRNA expression profiles—alongside validated target genes ELL2 and PDK4—demonstrate high diagnostic accuracy in distinguishing hypertrophic cardiomyopathy from healthy myocardium in transcriptomic datasets.
Answers are grounded in this paper and cite their sources.
miRNA-based ML models discriminate HCM in transcriptomic datasets with high AUCs; hypothesis-generating for clinical biomarkers pending prospective validation.
This study explores microRNAs (miRNAs) as biomarkers for hypertrophic cardiomyopathy (HCM), an inherited cardiac disease with clinical diversity and sudden death risk. Using bioinformatics and machine learning (ML), Gene Expression Omnibus (GEO) datasets were analysed to identify miRNA signatures for early detection, risk assessment, and personalised treatment of HCM. Differential expression analysis of three GEO datasets identified 155 differentially expressed genes (DEGs) and 5 differentially expressed miRNAs (DE-miRNAs). Functional annotation and pathway analysis revealed their roles in inflammatory responses, extracellular matrix organisation, and cellular stress responses. Notably, upregulated (COL21A1, PROM1) and downregulated (FOS, BTG2, ELL2, PDK4, SERPINE1, SRGN, TIPARP) genes were detected as potential DE-miRNA targets. Validation highlighted importance of ELL2 and PDK4 in HCM pathology. Support Vector Machine (SVM) and Random Forest (RF) models demonstrated high predictive accuracy for HCM using DE-miRNAs, suggesting new paths for early diagnosis and personalised therapy.
No takes yet. Share an insight, caveat, or question.
Yamasan et al. (2025) studied Hypertrophic cardiomyopathy (HCM) (n=466). Differentially expressed microRNA (DE-miRNA) panels analyzed with Support Vector Machine (SVM) and Random Forest (RF) machine learning models vs. Control individuals without cardiac diseases (unused donor hearts with normal function) was evaluated on Diagnostic classification of hypertrophic cardiomyopathy versus healthy controls using machine learning models trained on 5 DE-miRNAs (or an expanded 26-miRNA panel) (AUC 0.953 for 5 DE-miRNA SVM (AUC 0.995 for expanded 26-miRNA SVM and RF), 95% CI 0.882-1). Support Vector Machine and Random Forest models using 5 differentially expressed miRNAs discriminated HCM from healthy controls with AUCs of 0.953 and 0.922, improving to 0.995 with 26 miRNAs.
Synapse has enriched 10 related papers. Consider them for comparative context: